Αποτελέσματα Αναζήτησης
CHL Medical Partners is a private investment firm focused on starting and growing healthcare services businesses. more. Learn about the innovative, market leading healthcare services companies that CHL helped create and finance.
- Contact
CHL Medical Partners 113 Post Road East Westport, CT 06880...
- Team
CHL invests in... Partners. Jeffrey J. Collinson Myles D....
- Themes
The continued development of new technology, drugs, and...
- About
Overview. CHL Healthcare Partners is an investment firm...
- Portfolio
Ambra Health has developed a cloud-based radiology...
- Timothy F. Howe
He went on to form Collinson Howe Venture Partners (“CHVP”)...
- Myles D. Greenberg
Myles joined CHL Medical Partners in 2004. He has led...
- An Early Stage Healthcare Services Investor
Greg joined CHL Medical Partners in 2001. Prior to that,...
- Contact
CHL Healthcare Partners is an investment firm focused on starting and growing successful healthcare businesses.
CHL Medical Partners is one of the few investment firms focused on early stage investments in healthcare services. We invest early in a company’s development, often at the seed or start-up phase. We are typically the lead investor, structuring the financing and helping to build a long-term syndicate of co-investors.
5 Φεβ 2016 · Founded in 1997, CHL Medical Partners is a venture capital investment firm based in Westport, Connecticut. The firm makes early-stage investments in the life sciences and healthcare services sectors. This firm is a Registered Investment Adviser (RIA).
Founded in 1997, CHL Medical Partners was a Connecticut-based private equity firm that specialised in early-stage investments in life sciences, technology and healthcare companies across the United States.
CHL Medical Partners is a venture capital firm founded in 1990, managing funds with combined committed capital of more than $300 million. We invest principally in start-up and early stage companies in the medical sector.
CHL Medical Partners, an American venture capital firm, invests in biotechnology, molecular diagnostic, and medical device companies.
